PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
•2.1 Preface
•2.2 Preface
•2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE
•Market ecosystem
•Market characteristics
•Market segmentation analysis

PART 04: MARKET SIZING
•Market definition
•Market sizing 2018
•Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS
•Bargaining power of buyers
•Bargaining power of suppliers
•Threat of new entrants
•Threat of substitutes
•Threat of rivalry
•Market condition

PART 06: MARKET SEGMENTATION BY TYPE
•Market segmentation by type
•Comparison by type
•Non-surgical procedures - Market size and forecast 2018-2023
•Surgical procedures - Market size and forecast 2018-2023
•Market opportunity by type

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
•Geographic segmentation
•Geographic comparison
•North America - Market size and forecast 2018-2023
•Europe - Market size and forecast 2018-2023
•Asia - Market size and forecast 2018-2023
•ROW - Market size and forecast 2018-2023
•Key leading countries
•Market opportunity

PART 09: DRIVERS AND CHALLENGES
•Market drivers
•Market challenges

PART 10: MARKET TRENDS
•Technological advances
•Growing number of hospitals and surgeons specializing in cosmetic surgery
•Rising demand for aesthetic procedures

PART 11: VENDOR LANDSCAPE
•Overview
•Landscape disruption

PART 12: VENDOR ANALYSIS
•Vendors covered
•Vendor classification
•Market positioning of vendors
•ALLERGAN
•Bausch Health
•Galderma laboratories
•Hologic Inc.
•Merz Pharma

PART 13: APPENDIX
•Research methodology
•List of abbreviations

List of Exhibits
Exhibit 01: Global healthcare market
Exhibit 02: Segments of global healthcare market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ billions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Type - Market share 2018-2023 (%)
Exhibit 18: Comparison by type
Exhibit 19: Non-surgical procedures - Market size and forecast 2018-2023 ($ billions)
Exhibit 20: Non-surgical procedures - Year-over-year growth 2019-2023 (%)
Exhibit 21: Surgical procedures - Market size and forecast 2018-2023 ($ billions)
Exhibit 22: Surgical procedures - Year-over-year growth 2019-2023 (%)
Exhibit 23: Market opportunity by type
Exhibit 24: Customer landscape
Exhibit 25: Market share by geography 2018-2023 (%)
Exhibit 26: Geographic comparison
Exhibit 27: North America - Market size and forecast 2018-2023 ($ billions)
Exhibit 28: North America - Year-over-year growth 2019-2023 (%)
Exhibit 29: Europe - Market size and forecast 2018-2023 ($ billions)
Exhibit 30: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 31: Asia - Market size and forecast 2018-2023 ($ billions)
Exhibit 32: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 33: ROW - Market size and forecast 2018-2023 ($ billions)
Exhibit 34: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 35: Key leading countries
Exhibit 36: Market opportunity
Exhibit 37: Impact of drivers and challenges
Exhibit 38: Vendor landscape
Exhibit 39: Landscape disruption
Exhibit 40: Vendors covered
Exhibit 41: Vendor classification
Exhibit 42: Market positioning of vendors
Exhibit 43: ALLERGAN - Vendor overview
Exhibit 44: ALLERGAN - Business segments
Exhibit 45: ALLERGAN - Organizational developments
Exhibit 46: ALLERGAN - Segment focus
Exhibit 47: ALLERGAN - Key offerings
Exhibit 48: Bausch Health - Vendor overview
Exhibit 49: Bausch Health - Business segments
Exhibit 50: Bausch Health - Organizational developments
Exhibit 51: Bausch Health - Geographic focus
Exhibit 52: Bausch Health - Segment focus
Exhibit 53: Bausch Health - Key offerings
Exhibit 54: Galderma laboratories - Vendor overview
Exhibit 55: Galderma laboratories - Business segments
Exhibit 56: Galderma laboratories - Organizational developments
Exhibit 57: Galderma laboratories - Key offerings
Exhibit 58: Hologic Inc. - Vendor overview
Exhibit 59: Hologic Inc. - Business segments
Exhibit 60: Hologic Inc. - Organizational developments
Exhibit 61: Hologic Inc. - Geographic focus
Exhibit 62: Hologic Inc. - Segment focus
Exhibit 63: Hologic Inc. - Key offerings
Exhibit 64: Merz Pharma - Vendor overview
Exhibit 65: Merz Pharma - Product segments
Exhibit 66: Merz Pharma - Organizational developments
Exhibit 67: Merz Pharma - Geographic focus
Exhibit 68: Merz Pharma - Key offerings
Exhibit 69: Validation techniques employed for market sizing

Companies Mentioned
. ALLERGAN
. Bausch Health
. Galderma laboratories
. Hologic Inc.
. and Merz Pharma